
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
A new era in the treatment of migraine headache arrived with development of a revolutionary class of drugs known as the triptans.The book describes the development in this class of drugs, starting with the discovery of sumatriptin, covers the pharmacology and the mechanisms of action of the full range of triptans, before comparing their clinical efficacy and tolerability. Each drug is described by the company who produces it and then reviewed, based on experimental and clinical evidence, by independent scientists.This comprehensive review will provide clinicians with guidance on which triptan to select for which patient. The editors have gathered together the leading international experts to produce a book that will appeal to all neurologists and general physicians caring for headache patients as well as those with research interests in the field.
This volume investigates the pharmacological development, clinical efficacy, and therapeutic application of the triptan class of drugs in the treatment of migraine headaches. The editors, Michel Ferrari, Jes Olesen, and Patrick Humphrey, compile contributions from leading international experts to establish a standardized framework for understanding these medications. By synthesizing experimental data with clinical observations, the text provides a structured approach for physicians to evaluate and select appropriate treatments for individual patients.
What You Will Find
Scope Limits
Experts recognize this volume as a foundational reference for neurologists and general practitioners specializing in headache management. Readers frequently note the technical density of the prose, which serves as a rigorous resource for clinicians and researchers in the field of migraine therapeutics.
Page Count:
360
Publication Date:
2001-12-20
Publisher:
Oxford University Press
ISBN-10:
0192632140
ISBN-13:
9780192632142
No comments yet. Be the first to share your thoughts!